Skip to main content Skip to search Skip to main navigation
Please feel free to contact us via our order hotline:
07626 974 9700
(Mon-Fri 8am-8pm, Sat 8am-12pm)

Recognising fatty liver: Typical symptoms, causes and diagnosis

News
2026-11-19_Fettleber01.jpg?ts=1794910268

Figure 1: A fatty liver develops when an excessive amount of fat accumulates in the liver cells. The condition is often not detected for a long time and can have various causes.

A fatty liver often remains unnoticed for a long time but can impair health in the long term and increase the risk of other diseases. What makes the condition particularly insidious is that it usually causes no clear symptoms in the early stages and is therefore often discovered incidentally. But how can a fatty liver be recognised, which groups of people are particularly at risk and how is the condition medically diagnosed? In this article you will learn, among other things, which symptoms may indicate a fatty liver, which causes and risk factors play a role, and which targeted measures can support your liver health and effectively prevent a fatty liver.

What exactly is a fatty liver?

2026-11-19_Fettleber02.jpg?ts=1794910268

Figure 2: Different forms of fatty liver are distinguished. In some affected individuals it can be accompanied by inflammation and progressive scarring.

When an excessive amount of fat accumulates in the liver cells, this is called a fatty liver. Medically, this is also referred to as hepatic steatosis. Normally the liver contains only small amounts of fat. If the fat proportion increases, the organ can become increasingly impaired. A fatty liver often develops gradually and initially remains unnoticed because in many cases it causes no symptoms. Different forms are generally distinguished. The metabolic-associated fatty liver (MASLD) is mainly associated with metabolic disorders such as overweight, insulin resistance, type 2 diabetes and elevated blood lipid levels.1 In addition, there is alcohol-related fatty liver, which can result from regular or high alcohol consumption.2 Mixed forms are also possible.

It is important to distinguish between simple fatty liver and advanced liver damage. A pure accumulation of fat does not automatically mean that inflammation is already present. However, if inflammation of the liver tissue develops in addition, the metabolic-associated form is referred to as MASH (“metabolic dysfunction-associated steatohepatitis”). If this persists over a long period, the liver tissue can increasingly scar. This process should be taken seriously, as progressive scarring can lead to liver fibrosis and, in advanced stages, to liver cirrhosis.3

Non-alcohol-related fatty liver: the liver can become fatty even without alcohol

A fatty liver can also develop in people who drink little or no alcohol. For a long time this form was referred to as non-alcoholic fatty liver disease, abbreviated NAFLD (“non-alcoholic fatty liver disease”). Today, fat deposition in the liver in combination with at least one cardiometabolic risk factor is predominantly referred to as MASLD. These include, for example, overweight, elevated blood sugar levels, unfavourable blood lipid levels or high blood pressure. The newer designation therefore places a greater focus on metabolic health.

Insulin resistance often plays an important role: if the body’s cells respond less sensitively to insulin, more fatty acids can be released from adipose tissue and transported to the liver. At the same time, new fat formation in the liver can increase. If fat input and new fat production exceed breakdown and export, excess fat is deposited in the liver cells. Therefore, abstaining from alcohol alone is not always sufficient to prevent a fatty liver. It is crucial to recognise and specifically treat any existing metabolic disorders.

Which symptoms can indicate a fatty liver?

Detecting a fatty liver is usually difficult because it often causes no or only very non-specific symptoms for a long time. Many affected people therefore do not initially notice that their liver is affected. When symptoms do occur, they are often not clearly attributable to a fatty liver. Possible signs include:

  • tiredness and exhaustion
  • a feeling of pressure in the right upper abdomen
  • general malaise
  • bloating and digestive problems

With advanced liver damage, especially in liver cirrhosis, further symptoms and visible changes may occur, for example:

  • yellowing of the skin and eyes (jaundice)
  • fluid accumulation in the abdominal cavity (ascites)
  • swollen legs, especially calves and ankles
  • increased tendency to bruise
  • muscle wasting and unintended weight loss

It is important to emphasise, however, that these symptoms do not reliably indicate a fatty liver. Persistent tiredness or a feeling of pressure in the upper abdomen, in particular, can have many different causes. Because a fatty liver is often asymptomatic, medical assessment and, if necessary, targeted investigations are advisable when risk factors are present.

Causes and risk factors: who is particularly at risk?

2026-11-19_Fettleber03.jpg?ts=1794910268

Figure 3: Overweight, visceral abdominal fat, insulin resistance and type 2 diabetes are among the most important risk factors for a metabolic-associated fatty liver. However, it can also occur in people of normal weight.

In many cases a fatty liver develops in connection with metabolic disorders that promote excessive fat deposition in the liver cells. Overweight (especially visceral abdominal fat), insulin resistance, type 2 diabetes, elevated blood lipid levels and high blood pressure are among the most important risk factors. An unfavourable diet high in heavily processed foods and sugary drinks, as well as lack of exercise, can also promote the development of a metabolic-associated fatty liver. Genetic factors that influence individual susceptibility to the disease also play a role.

In addition to these metabolic factors, regular or high alcohol consumption can also lead to fat deposition in the liver. Certain medications and diseases can also trigger it. However, a fatty liver does not affect only people who are overweight. Normal-weight people can also develop it.4 In such cases, an unfavourable fat distribution, insulin resistance or a corresponding genetic predisposition are often decisive.

How is a fatty liver diagnosed?

Because a fatty liver often causes no clear symptoms, it is not infrequently discovered incidentally during a medical examination. If there is a corresponding suspicion, various diagnostic methods can be used. An anamnesis is usually taken first, during which the treating doctor asks about possible risk factors such as overweight, diabetes, alcohol consumption, dietary habits and medication use. Blood tests can then be carried out. These typically include the main liver enzymes ALT (GPT), AST (GOT) and gamma-GT. Elevated values can indicate stress or damage to the liver, but they do not definitively prove a fatty liver. Conversely, normal liver values do not rule out fat deposition in the liver.

Central to the diagnosis is ultrasound examination (sonography). This often allows a fatty liver to be detected by a changed echo pattern of the liver tissue. However, mild fat deposits are not always reliably detected.5 To further assess possible liver damage, additional tests may be required. These include, for example, elastography, which can assess the stiffness of the liver tissue and thus possible scarring (fibrosis). Blood-based risk scores such as the FIB-4 index can also help estimate the risk of advanced fibrosis. In certain cases, magnetic resonance imaging (MRI) or a liver biopsy may be indicated. Which investigations are necessary depends on the individual health circumstances and the findings to date.

What potential consequences can an untreated fatty liver have?

A fatty liver does not always lead to severe liver damage. For many people it remains a simple fat accumulation in the long term, which can often be reversed by changes in lifestyle. However, in some patients inflammation of the liver tissue can develop in addition. If this persists, the liver tissue can increasingly scar. Doctors initially refer to this as liver fibrosis. If this process progresses further, it can develop into liver cirrhosis, in which the normal liver structure is progressively destroyed and organ function may be impaired.

In advanced stages further complications are possible. These include, among others, fluid accumulation in the abdominal cavity (ascites), an increased tendency to bleed, impaired detoxification function of the liver and an increased risk of liver cancer. In addition, metabolic-associated fatty liver is closely linked to an increased risk of cardiovascular disease and type 2 diabetes. However, it would be wrong to infer that every fatty liver inevitably progresses. The individual risk depends, for example, on existing metabolic diseases, genetic factors and the extent of any liver fibrosis. Early diagnosis and targeted measures can help relieve the liver and prevent progression of the disease.

From giving up alcohol to metabolic control: 10 tips to holistically prevent a fatty liver

2026-11-19_Fettleber04.jpg?ts=1794910268

Figure 4: Among other measures, minimal alcohol consumption, regular exercise and control of key metabolic values can help reduce the risk of a fatty liver.

A fatty liver often develops gradually and remains unnoticed by those affected for a long time. All the more reason to be mindful of factors that favour excessive fat deposition in the liver. In addition to moderating alcohol intake, control of blood sugar, blood lipids and waist circumference plays a key role. The following ten measures can help you reduce your personal risk and support your liver health in the long term.

  • Avoid alcohol where possible: Alcohol is metabolised in the liver and can promote fat deposition in liver cells. If you want to effectively prevent a fatty liver, you should therefore avoid alcoholic beverages where possible or at least significantly reduce consumption.
  • Eliminate sugary drinks from your diet: Soft drinks, energy drinks and other heavily sweetened beverages provide large amounts of rapidly available carbohydrates. High consumption of sugary drinks can promote the development of a metabolic-associated fatty liver.6
  • Keep an eye on your waist measurement: Visceral abdominal fat is closely linked to insulin resistance and increased fat deposition in the liver. An increasing waist circumference can therefore be an indicator of elevated metabolic risk, even if it alone does not prove a fatty liver.
  • Act early against insulin resistance: Reduced sensitivity of body cells to insulin can impair fat metabolism and promote the development of a fatty liver. Pay attention to good metabolic health and have possible risk factors checked by a doctor.
  • Have your blood sugar levels checked: Elevated blood sugar levels and type 2 diabetes are important risk factors for a metabolic-associated fatty liver. Regular medical checks are particularly advisable if there is already overweight, a family history of diabetes or other metabolic abnormalities.
  • Check your triglyceride and cholesterol levels: Elevated triglyceride levels often occur together with a fatty liver and can indicate disturbances in fat metabolism. Have your blood lipid levels checked as part of medical preventive examinations and treat abnormal values specifically.
  • Incorporate physical activity into your daily routine: Physical activity can improve insulin sensitivity and reduce liver fat content — even independently of weight loss. A combination of aerobic and resistance training that can be sustained in everyday life is particularly recommended.
  • Pay attention to sustainable weight development: Overweight — especially an increased accumulation of abdominal fat — raises the risk of developing a fatty liver. With existing overweight, gradual weight loss can help reduce fat deposition in the liver. Radical diets and very rapid weight loss are not recommended.
  • Review medications and supplements that may burden the liver: Some medications can promote fat deposition in the liver as a side effect. Discuss possible risks with your doctor and do not take herbal products or dietary supplements uncritically. However, never stop prescribed medications on your own.
  • Have individual risk factors assessed early: Because a fatty liver often causes no symptoms, medical assessment is particularly important when risk factors are present. People with type 2 diabetes, overweight, high blood pressure or abnormal blood lipid levels should directly ask whether a targeted liver examination may be advisable.

Disclaimer

This article does not replace treatment by a qualified practitioner. The basis for this article is studies and current literature. It must not be used for self-diagnosis or self-treatment. Discuss any inspirations from this article with a practitioner you trust.

Biography

Katharina Korbach regularly writes blog posts on medicinal plants and natural active ingredients for the Narayana Verlag. She developed an interest in language early on and began writing her own literary texts. A serious illness during her school-leaving exams prompted an intensive engagement with health and nutrition topics that continues to this day. After repeated failure of conventional medical treatment methods, she decided on a more self-effective, naturopathic therapeutic approach. A plant-based diet was a key element in her recovery.

Katharina studied Cultural Studies (B.A.) and Applied Literary Studies (M.A.). In 2022 she published her debut novel "Sperling" with Berlin Verlag. She now lives in Berlin as a freelance author, medical editor and lecturer. In her free time she prefers to spend time with friends or doing barre training. She also loves to travel and try new vegan recipes.


References

  1. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024 Sep. https://pubmed.ncbi.nlm.nih.gov/38851997/
  2. Arab JP, Díaz LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M, Bataller R, Burton R, Chokshi S, Francque SM, Krag A, Lackner C, Lee BP, Liangpunsakul S, MacClain C, Mandrekar P, Mitchell MC, Morgan MY, Morgan TR, Pose E, Shah VH, Shawcross D, Sheron N, Singal AK, Stefanescu H, Terrault N, Trépo E, Moreno C, Louvet A, Mathurin P. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. J Hepatol. 2025 Apr. https://pubmed.ncbi.nlm.nih.gov/39608457/
  3. Hagström H, Shang Y, Hegmar H, Nasr P. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024 Oct. https://pubmed.ncbi.nlm.nih.gov/39243773/
  4. Danpanichkul P, Suparan K, Kim D, Wijarnpreecha K. What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. J Clin Med. 2024 Jan 3. https://pubmed.ncbi.nlm.nih.gov/38202285/
  5. Wilson MP, Tang A, Low G, Zhang LX, Costa AF, Pang E, Chang S, Medellin A, Shaheen AA, Dana J, Millo N, Kielar A, Swain M, Leung V, Fung D, Hurrell C, Fung C. Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI. Can Assoc Radiol J. 2026 Feb. https://pubmed.ncbi.nlm.nih.gov/40765159/
  6. Chen H, Wang J, Li Z, Lam CWK, Xiao Y, Wu Q, Zhang W. Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis. Int J Environ Res Public Health. 2019 Jun 21. https://pubmed.ncbi.nlm.nih.gov/31234281/

Figure 1: saturnvh/shutterstock.com ; Figure 2: SoftSheep/Shutterstock.com ; Figure 3: PawelKacperek/shutterstock.com ; Figure 4: baranq/shutterstock.com

19 November 2026

Katharina Korbach